Key regions: Australia, Italy, France, South Korea, Brazil
Sweden, a country in Northern Europe, has a well-established healthcare system that is highly accessible to its citizens. The country's healthcare system is publicly funded and provides universal coverage to all residents. The Vaccines market in Sweden has been developing in a particular way due to several factors.
Customer preferences: In Sweden, there is a high level of awareness and acceptance of vaccination. Most Swedes have a positive attitude towards vaccines, and the majority of the population believes that vaccines are safe and effective. The country has a well-organized vaccination program, and vaccines are widely available to the public. Sweden has a high vaccination coverage rate, which is due to the population's trust in the healthcare system and the government's efforts to promote vaccination.
Trends in the market: The Vaccines market in Sweden has been growing steadily over the years. The market is expected to continue to grow due to an increase in the number of infectious diseases and the aging population. The demand for vaccines has also increased due to the COVID-19 pandemic. The pandemic has highlighted the importance of vaccination and has led to an increase in public awareness and demand for vaccines. The market is also expected to benefit from the development of new vaccines and the expansion of the vaccination program.
Local special circumstances: Sweden has a well-established healthcare system that is publicly funded, and vaccines are provided free of charge to the public. The country has a high level of trust in the healthcare system, and the government plays a significant role in promoting vaccination. The government has also implemented policies to ensure that vaccines are accessible to all residents, including those in remote areas.
Underlying macroeconomic factors: Sweden has a stable economy, with a high standard of living and a strong healthcare system. The country has a high level of investment in healthcare and research, which has led to the development of new vaccines and treatments. The government also provides funding for research and development in the healthcare sector, which has contributed to the growth of the Vaccines market in Sweden. The country's aging population and the increase in the number of infectious diseases have also contributed to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
